Abstract:Hexavalent chromium [Cr(VI)] is a common environmental pollutant and chronic exposure to Cr(VI) causes lung cancer and other types of cancer in humans, although the mechanism of Cr(VI) carcinogenesis remains elusive. Cr(VI) has been considered as a genotoxic carcinogen, but accumulating evidence indicates that Cr(VI) also causes various epigenetic toxic effects that play important roles in Cr(VI) carcinogenesis. However, it is not clear how Cr(VI)-caused epigenetic dysregulations contributes to Cr(VI) carcinogenesis. This study investigates whether Cr(VI) epigenetic toxic effect has an impact on its genotoxic effect. It was found that chronic low dose of Cr(VI) exposure time-dependently down-regulates the expression of a critical DNA damage repair protein O6-methylguanine-DNA methyltransferase (MGMT), leading to the increases of the levels of the highly mutagenic and carcinogenic DNA lesion O6-methylguanine (O6-MeG) in human bronchial epithelial BEAS-2B cells. Moreover, the levels of MGMT and O6-MeG in chronic Cr(VI) exposure-caused human lung cancer tissues are also significantly lower and higher than that in the adjacent normal lung tissues, respectively. It was further determined that chronic low dose of Cr(VI) exposure-transformed BEAS-2B cells display impaired DNA damage repair capacity and a high sensitivity to the toxicity of the alkylating chemotherapeutic drug Temozolomide. In contrast, stably overexpressing MGMT in parental BEAS-2B cells reverses chronic low dose of Cr(VI) exposure-caused DNA damage repair deficiency and significantly reduces cell transformation by Cr(VI). Further mechanistical studies revealed that chronic low dose of Cr(VI) exposure down-regulates MGMT expression through epigenetic mechanisms by increasing DNA methylation and histone H3 repressive modifications. Taken together, these findings suggest that epigenetic down-regulation of a crucial DNA damage repair protein MGMT contributes significantly to the genotoxic effect and cell transformation caused by chronic low dose of Cr(VI) exposure.

Modulation of histone methylation and MLH1 gene silencing by hexavalent chromium

Hexavalent chromium promotes differential binding of CTCF to its cognate sites in Euchromatin

DNA methylation modifications induced by hexavalent chromium

Cr(VI)-induced Methylation and Down-Regulation of DNA Repair Genes and Its Association with Markers of Genetic Damage in Workers and 16HBE Cells.

Epigenetic downregulation of O6-methylguanine-DNA methyltransferase contributes to chronic hexavalent chromium exposure-caused genotoxic effect and cell transformation

Modulation of Homologous Recombination Repair Gene Polymorphisms on Genetic Damage in Chromate Exposed Workers.

DNA mismatch repair protein Mlh1 is required for tetravalent chromium intermediate-induced DNA damage.

Epigenetic and epitranscriptomic mechanisms of chromium carcinogenesis

The Effect of Global DNA Methylation on PDCD5 Expression in the PBMC of Occupational Chromate Exposed Workers

Epigenetic alterations of CXCL5 in Cr(VI)-induced carcinogenesis

Decreased 8-Oxoguanine DNA Glycosylase 1 (hogg1) Expression and DNA Oxidation Damage Induced by Cr (VI).

The Role of Epigenetics in the Toxic Effects Induced by Hexavalent Chromium

Molecular Mechanisms Of Chromium-Induced Carcinogenesis

Hexavalent Chromium (cr(vi)) Down-Regulates Acetylation of Histone H4 at Lysine 16 Through Induction of Stressor Protein Nupr1.

Oxidative Dna Damage and Global Dna Hypomethylation Are Related to Folate Deficiency in Chromate Manufacturing Workers

Cellular Senescence Mediates Hexavalent Chromium-Associated Lung Function Decline: Insights from a Structural Equation Model

New Evidences about Adverse Health Effects Based on Chromate Environmental and Biological Exposure Assessment in Chromate Manufacturing Workers

Blood chromium exposure, immune inflammation and genetic damage: Exploring associations and mediation effects in chromate exposed population

HMGA2 Mediates Cr (Vi)-Induced Metabolic Reprogramming Through Binding to Mitochondrial D-Loop Region.

Hexavalent chromium induces mitochondrial dynamics disorder in rat liver by inhibiting AMPK/PGC-1α signaling pathway